During the past decade, Grace Research, LLC conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grace Research, LLC" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grace Research, LLC" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Grace Research, LLC" are "Heart Failure" (4 trials), "Cardiovascular Disease" (3 trials), "ASCVD" (1 trials), "Acute Coronary Syndromes" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Grace Research, LLC" in a lesser frequency.

Most popular intervention types in "Grace Research, LLC" are "Drug" (13 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Empagliflozin" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Acetylsalicylic acid" (1 trials) and "Acetylsalicylic acid placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grace Research, LLC" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Grace Research, LLC". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Grace Research, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Grace Research, LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".